The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery. Panelists: Kevin Flanigan, MD, Nationwide Children’s Hospital Melissa Spencer, PhD, UCLA 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 4 years ago You may also like 21:06 Capricor Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 18:40 Sarepta Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 17:20 Pfizer Inc. 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 21:45 Audentes Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 19:10 Solid Biosciences 4 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 13:05 Astellas Pharma 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 12:31 Santhera Pharmaceuticals 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 10:23 Cumberland Pharmaceuticals 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets «1…1819202122…25»Page 20 of 25
by: Parent Project Muscular Dystrophy
